Dysfunction of Variant Human Antithrombins - Peter Gettins

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Heart, Lung, and Blood Institute (NHLBI)
Type: Research Project (R01)
Project #: 5R01HL049234-04
Application #: 2225358
Study Section: Hematology Subcommittee 2 (HEM)

Project Start: 1993-01-01
Project End: 1997-12-31
Budget Start: 1996-01-01
Budget End: 1996-12-31
Support Year: 4
Fiscal Year: 1996
Total Cost
Indirect Cost

Institution

Name: University of Illinois at Chicago
Department: Biochemistry
Type: Schools of Medicine
DUNS #: 121911077

City: Chicago
State: IL
Country: United States
Zip Code: 60612

Related projects


NIH 1997 R01 HL	Dysfunction of Variant Human Antithrombins Gettins, Peter G.W. / University of Illinois at Chicago
NIH 1996 R01 HL	Dysfunction of Variant Human Antithrombins Gettins, Peter G.W. / University of Illinois at Chicago
NIH 1995 R01 HL	Dysfunction of Variant Human Antithrombins Gettins, Peter G.W. / University of Illinois at Chicago
NIH 1994 R01 HL	Dysfunction of Variant Human Antithrombins Gettins, Peter G.W. / University of Illinois at Chicago
NIH 1993 R01 HL	Basis for Dysfunction of Variant Human Antithrombins Gettins, Peter G.W. / Vanderbilt University Medical Center

Publications

Huang, Xin; Dementiev, Alexey; Olson, Steven T et al. (2010) Basis for the specificity and activation of the serpin protein Z-dependent proteinase inhibitor (ZPI) as an inhibitor of membrane-associated factor Xa. J Biol Chem 285:20399-409

Gettins, Peter G W; Olson, Steven T (2009) Activation of antithrombin as a factor IXa and Xa inhibitor involves mitigation of repression rather than positive enhancement. FEBS Lett 583:3397-400

Gettins, Peter G W; Olson, Steven T (2009) Exosite determinants of serpin specificity. J Biol Chem 284:20441-5

Gettins, P G (1994) 1H- and 19F-NMR approaches to the study of the structure of proteins larger than 25 kDa. Int J Biol Macromol 16:227-35

Comments

Be the first to comment on Peter Gettins's grant